Li Huo
Impact in
- Oncology top 2%
- Peptidase Inhibition and Analysis
- Nephrology top 2%
- Parathyroid Disorders and Treatments
Papers in
- Oncology 67
- Peptidase Inhibition and Analysis 35
- Lung Cancer Research Studies 13
- Nephrology 25
- Parathyroid Disorders and Treatments 25
- Co-authors
- Jie Ding (28 shared papers)Xiang Li (22 shared papers)Haiqun Xing (31 shared papers)Wenjia Zhu (30 shared papers)Shaobo Yao (10 shared papers)Marcus Hacker (17 shared papers)Mengxin Xu (5 shared papers)Junyi Chen (5 shared papers)
- Journals
- European Journal of Nuclear Medicine and Molecular Imaging (20 papers)Journal of Nuclear Medicine (16 papers)EJNMMI Physics (5 papers)Journal of Nuclear Cardiology (5 papers)Clinical Nuclear Medicine (44 papers)
- Partner nations
- ChinaUnited StatesAustria
In The Last Decade
Li Huo
218 papers receiving 3.6k citations
Li Huo's Hit Papers
Peers
Comparison fields: 5 of 134
- Oncology 1.5k
- Nephrology 294
- Radiology, Nuclear Medicine and Imaging 725
- Cancer Research 422
- Surgery 879
Countries citing papers authored by Li Huo
This map shows the geographic impact of Li Huo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Huo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Huo more than expected).
Fields of papers citing papers by Li Huo
This network shows the impact of papers produced by Li Huo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Huo. The network helps show where Li Huo may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Huo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 232 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 145 | |
| 2 | Covalent targeted radioligands potentiate radionuclide therapy Hit paper breakdown → | 2024 | 131 |
| 3 | 2020 | 130 | |
| 4 | 2020 | 122 | |
| 5 | 2020 | 105 | |
| 6 | 2017 | 101 | |
| 7 | 2019 | 101 | |
| 8 | 2019 | 94 | |
| 9 | 2016 | 86 | |
| 10 | 2021 | 71 | |
| 11 | 2020 | 69 | |
| 12 | 2019 | 67 | |
| 13 | 2021 | 64 | |
| 14 | 2019 | 60 | |
| 15 | 2021 | 54 | |
| 16 | 2015 | 52 | |
| 17 | 2022 | 45 | |
| 18 | 2023 | 44 | |
| 19 | 2002 | 42 | |
| 20 | 2021 | 39 |
About Li Huo
Li Huo is a scholar working on Oncology, Nephrology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Surgery, having authored 232 papers that have together received 3.6k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (35 papers), Neuroendocrine Tumor Research Advances (25 papers), Parathyroid Disorders and Treatments (25 papers), Medical Imaging Techniques and Applications (20 papers), Adrenal and Paraganglionic Tumors (15 papers), Medical Imaging and Pathology Studies (15 papers), Lung Cancer Research Studies (13 papers) and Radiopharmaceutical Chemistry and Applications (12 papers). The work is most often cited by research in Oncology (1.5k citations), Nephrology (294 citations), Radiology, Nuclear Medicine and Imaging (725 citations), Cancer Research (422 citations) and Surgery (879 citations). Li Huo has collaborated with scholars based in China, United States and Austria. Frequent co-authors include Jie Ding, Xiang Li, Haiqun Xing, Wenjia Zhu, Shaobo Yao, Marcus Hacker, Mengxin Xu, Junyi Chen, Ximin Shi and Haitao Zhao. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Journal of Nuclear Medicine, EJNMMI Physics, Journal of Nuclear Cardiology and Clinical Nuclear Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.